NCT03046316View on ClinicalTrials.gov

Local Therapy in Advanced NSCLC With Non-progressive Disease (PD) After First Line Therapy

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2026

Conditions
Lung Neoplasms
Interventions
OTHER

local consolidative treatment

local consolidative treatment to primary or metastases, which includes surgery, radiotherapy or interventional therapy

Trial Locations (1)

510080

RECRUITING

Guangdong General Hospital, Guangzhou

All Listed Sponsors
lead

Guangdong Association of Clinical Trials

OTHER

NCT03046316 - Local Therapy in Advanced NSCLC With Non-progressive Disease (PD) After First Line Therapy | Biotech Hunter | Biotech Hunter